Subgroup Analysis Of A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study Of Tralokinumab, An Anti-IL-13 Monoclonal Antibody, In Moderate To Severe Asthma

2012 ◽  
Author(s):  
Edward Piper ◽  
Dewei She ◽  
Nestor A. Molfino
Keyword(s):  
Monoclonal Antibody ◽  
Severe Asthma ◽  
Subgroup Analysis ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

2018 ◽  
Vol 85 (2) ◽  
pp. 304-315 ◽  
Author(s):  
Joanne Ellis ◽  
Andre Maurik ◽  
Lea Fortunato ◽  
Sophie Gisbert ◽  
Keguan Chen ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Healthy Subjects ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

A randomized, double-blind, placebo-controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

1995 ◽  
Vol 38 (8) ◽  
pp. 1097-1106 ◽  
Author(s):  
Peter A. Van Der Lubbe ◽  
Ben A. C. Dijkmans ◽  
Hendrik M. Markusse ◽  
Ulla Nässander ◽  
Ferdinand C. Breedveld
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Early Rheumatoid Arthritis ◽  
Antibody Therapy ◽  
Controlled Study ◽  
Monoclonal Antibody Therapy ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document